Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Sopharma Properties REIT EBITDA Margin % Related Terms
Sopharma Properties REIT EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the REIT - Diversified subindustry, Sopharma Properties REIT's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sopharma Properties REIT EBITDA Margin % vs REITs Industry
For the REITs industry and Real Estate sector, Sopharma Properties REIT's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Sopharma Properties REIT's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sopharma Properties REIT (XBUL:SFI) has a EBITDA Margin % of 0.00% as of Jun. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Sopharma Properties REIT and its competitors. Over the past decade, Sopharma Properties REIT's EBITDA Margin % has ranged from 64.57 to 112.30. According to the industry distribution chart, Sopharma Properties REIT ranks #146 out of 736 companies in the REITs industry, placing it in the top 19.8%.
Is Sopharma Properties REIT's EBITDA Margin % too high?
Sopharma Properties REIT's current EBITDA Margin % is 0.00%. Over the past 10 years, this metric has ranged from a low of 64.57 to a high of 112.30. Based on the distribution chart, Sopharma Properties REIT ranks #146 out of 736 companies in the REITs industry, which is in the top quartile — a strong position relative to peers. Overall, Sopharma Properties REIT has a GF Score™ of 68/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sopharma Properties REIT's EBITDA Margin % compare to VICI and WPC?
According to the REITs industry distribution chart, Sopharma Properties REIT ranks #146 out of 736 companies for EBITDA Margin %. This places Sopharma Properties REIT in the top 20% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 69.79. Historically, Sopharma Properties REIT's own EBITDA Margin % has ranged from 64.57 to 112.30 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a REITs company?
The median EBITDA Margin % among REITs companies is 69.79, based on 736 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Sopharma Properties REIT and its competitors. For the REITs industry, the median EBITDA Margin % is 69.79 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sopharma Properties REIT's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sopharma Properties REIT stock overvalued right now?
Based on GuruFocus' analysis, Sopharma Properties REIT (XBUL:SFI) is currently considered Significantly Undervalued. The stock's GF Value™ is €10.44, compared to a current price of €4.20 — trading 59.8% below its estimated fair value. The current EBITDA Margin % is 0.00%. Sopharma Properties REIT's overall GF Score™ is 68/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Sopharma Properties REIT (XBUL:SFI), the current EBITDA Margin % is 0.00% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sopharma Properties REIT (XBUL:SFI) Overvalued in 2026?
Based on GuruFocus' analysis, Sopharma Properties REIT stock appears to be undervalued.
The current stock price of €4.20 is trading 59.8% below its estimated GF Value™ of €10.44.
GuruFocus considers Sopharma Properties REIT to be Significantly Undervalued.
Key valuation signals for XBUL:SFI:
EBITDA Margin %: 0.00%
GF Value™: €10.44 vs. price of €4.20 (59.8% below fair value)
No single metric tells the full story. See the XBUL:SFI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XBUL:SFI has been successfully added to your 
